Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response.

Pazdirek, Filip; Minarik, Marek; Benesova, Lucie; Halkova, Tereza; Belsanova, Barbora; Macek, Milan; Stepanek, Lubomír; Hoch, Jiri

Pazdirek, Filip; Minarik, Marek; Benesova, Lucie; Halkova, Tereza; Belsanova, Barbora; Macek, Milan; Stepanek, Lubomír; Hoch, Jiri.

Afiliação

Pazdirek F; Department of Surgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.
Minarik M; Department of Surgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.
Benesova L; Elphogene, Prague, Czechia.
Halkova T; Center for Applied Genomics of Solid Tumors (CEGES), Genomac Research Institute, Prague, Czechia.
Belsanova B; Center for Applied Genomics of Solid Tumors (CEGES), Genomac Research Institute, Prague, Czechia.
Macek M; Elphogene, Prague, Czechia.
Stepanek L; Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.
Hoch J; Institute of Biophysics and Informatics, 1st Faculty of Medicine, Charles University, Prague, Czechia.

Front Oncol ; 10: 1028, 2020.

Article em En | MEDLINE | ID: mdl-32793464

Palavras-chave

biomarker; circulating tumor ctDNA; neoadjuvant chemoradiotherapy; prediction; prognosis; rectal cancer; response

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google